Objective: This study evaluated the diagnostic value of measuring the levels of procalcitonin (PCT) and C-reactive protein (CRP) to differentiate children co-infected with H1N1 influenza and bacteria from children infected with H1N1 influenza alone.
monly used to differentiate between bacterial and viral etiologies.
Although previous studies have focused on using CRP levels to detect bacterial co-infections in patients with H1N1 infections, the evidence from these studies is inconsistent. Studies suggested serum CRP as a potential diagnostic biomarker, 9-11 whereas Piacentini et al 12 found
that CRP levels were unable to distinguish bacterial co-infections from H1N1 infections. Another interesting biomarker is procalcitonin (PCT), the prohormone of calcitonin produced by C cells in the thyroid. Plasma PCT concentrations are low in healthy individuals and increase during bacterial, parasitic, or fungal infections, whereas they remain at normal levels during viral infections or non-infectious inflammatory reactions. 13 Studies attempting to assess PCT levels in patients with H1N1 infection have found that PCT helped to distinguish bacterial co-infections from H1N1 infections alone. 14, 15 Nevertheless, to the best of our knowledge, previous studies published to date have focused on adults 14, 15 and patients with severe disease 16 but have included few pediatric patients with H1N1 infections.
Thus, in the present study, we conducted a retrospective analysis of 3180 children with H1N1 infection to evaluate the diagnostic levels of serum PCT, CRP and WBC alone and in combination for differentiating bacterial co-infections from H1N1 influenza infections alone in children. These results could be used to provide a reliable clinical diagnostic support system for improving diagnostic accuracy and enabling the early treatment of bacterial co-infections accompanying H1N1 influenza infections.
| ME THODS

| Settings and participants
We performed a retrospective cohort study of consecutive patients with laboratory-confirmed H1N1 influenza infections, all of whom were children <5 years old who were hospitalized or received outpatient care from a tertiary-care hospital in Canton, China, between 
| Definitions
Patients diagnosed with H1N1 influenza infection confirmed by realtime reverse transcriptase polymerase chain reaction (RT-PCR) 17 of nasopharyngeal secretions or bronchoalveolar lavage (BAL) fluid samples within the first 48 hours of hospitalization were included in the study.
Bacterial co-infection was defined as a positive H1N1 influenza viral PCR result with one or more bacterial pathogens detected. Bacterial cultures were obtained from blood, valid sputum, and BAL fluid within the first 48 hours of hospitalization. We excluded patients who received antibiotics prior to hospitalization or who lacked bacterial cultures.
| Inflammatory biomarker (PCT, CRP, and WBC) measurements
Venous blood samples were collected from H1N1-infected patients upon admission. Serum PCT levels were determined using an enzyme-linked fluorescence analysis (ELFA, VIDAS BRAHMS PCT kit, bioMerieux SA, Marcy-l'Etoile, France). Serum CRP levels were determined using a BNPProSpec automatic protein analyzer (Dade Behring BN Prospec, Deerfield, IL, USA), 18 and WBC counts were analyzed by using a Sysmex XE-2100 hematology analyzer (Sysmex, Kobe, Japan). Furthermore, iterative biomarker(s) were selected (including biomarkers with P < 0.10) using automatic forward stepwise regression, and the multivariate logistic regression model was built.
| Statistical analysis
The performance of the models was then assessed by calculating the area under the receiver operating characteristic (ROC) curve (AUC). The AUC values were compared for each biomarker individually and in conjunction with biomarker models using the Hanley and McNeil method. 19 The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were also reported. The Youden index (sensitivity + specificity − 1) was used to determine the optimal ROC cutoff value. Moreover, 10-fold cross-validation to evaluate the robustness of the estimates obtained from the constructed model was performed as described previously. 20 Then, we averaged the AUC, sensitivity, and specificity values obtained from the 10-fold cross-validations to generate summary performance estimates.
All statistical analyses were performed using R Software, version 3.4.2 (www.r-project.org). A two-tailed P value < 0.05 was considered significant. Figure S1 shows the flowchart for the patients included in the study. During the study period, 3180 children with laboratory-confirmed H1N1 influenza infection were included, with a median age of 3.6 years (IQR, 1.8-4.7 years); 1784 (52.3%) were males. Among these patients, 226 (7.1%) had a proven bacterial co-infection. Streptococcus pneumoniae was the most frequent pathogen causing the bacterial co-infection in 82 (36.2%)
| RE SULTS
| Study population and bacterial pathogen characteristics
cases, followed by Staphylococcus aureus in 55 (24.3%) cases and
Pseudomonas aeruginosa in 34 (15.0%) cases (Table S1 ). Eight children (3.5%) displayed two positive respiratory tract bacterial cultures.
When the baseline characteristics and clinical outcomes of the H1N1 plus bacterial co-infection group were compared, children in the H1N1-alone group were older, but this result was not significant (median age, 2.5 vs 2.4 years, P = 0.197). Differences in gender or weight were not observed between the two groups;
however, the bacterial co-infection group showed significantly higher inpatient admission (14.3% vs 50.4%, P < 0.001) and ICU admission rates (2.6% vs 36.3%, P < 0.001) than patients in the H1N1-alone group. The bacterial co-infection group also required longer hospital stays (5 vs 10 days, P = 0.003) than H1N1-alone group and thus had much higher hospital costs (median hospital cost, 1213.2 vs 3467.3 RMB, P < 0.001). Moreover, a higher inhospital mortality rate was noted for the bacterial co-infection group than the H1N1-alone group (0.1% vs 4.8%, P < 0.001; Table 1 ).
| Comparison of serum PCT, CRP, and WBC levels between H1N1 alone and H1N1 with bacterial co-infection groups
Serum PCT, CRP, and WBC levels were analyzed to identify potential biomarkers that distinguished between H1N1 infections and H1N1
and bacterial co-infections. The median serum PCT, CRP, and WBC levels were all significantly higher in the H1N1 with bacterial coinfection group than in the H1N1-alone group (median PCT level, 
| Univariate and multivariate logistic regression analyses
Univariate analysis revealed significant associations of serum PCT, CRP, and WBC levels with co-infections with H1N1 and bacteria (odds ratio F I G U R E 1 Serum PCT (A), CRP (B), and WBC (C) levels in patients with H1N1 influenza who presented with and without bacterial coinfections. The differences between the H1N1-alone group and bacterial co-infection group were examined using the Wilcoxon rank-sum test 
| Comparison and validation of the model's diagnostic ability
Because serum PCT and CRP levels were independent predictors that differentiated patients with bacterial co-infections from pa- 
| D ISCUSS I ON
Bacterial co-infection is especially known to increase the mortality and morbidity of H1N1 influenza. Unfortunately, it is difficult to correctly diagnose bacterial co-infection based on only clinical criteria, while bacterial culturing is time-consuming. There is a crucial need to differentiate H1N1 patients with bacterial co-infection from those with H1N1 infection alone. The diagnostic and predictive value of serum PCT and CRP levels as biomarkers has been discussed in several studies. 10, 14, 15, 21 Shin et al 10 found that serum PCT was a good indicator in discriminating bacterial co-infections from H1N1 infection alone in 60 adult patients in ICU. Guervilly et al 21 reported that PCT values were significantly higher in patients with bacterial co-infections. In addition, PCT has been suggested to exclude bacterial co-infections in patients with H1N1 infection and to reliably and accurately reduce inappropriate antibiotic exposure.
14
Our results showed that serum PCT levels were significantly higher in patients with bacterial co-infection compared with those infected with H1N1 alone, confirming that PCT is associated with TA B L E 3 Discriminatory performance of WBC, CRP, PCT and the constructed model for detecting patients with H1N1 influenza and a bacterial co-infection The present study involved 3180 children with H1N1, 7.11% of whom presented a confirmed bacterial co-infection, after including both outpatients and inpatients. The proportion of bacterial co-infection was similar to that previously reported for H1N1.
Nevertheless, previous studies of children with H1N1 influenza infection reported a bacterial co-infection rate ranging from 18% to 60%. 23, 24 These rates may be overestimated because the previous studies were limited to pediatric patients in the ICU, which represent a population with moderate to severe H1N1 influenza infection.
Moreover, children with bacterial co-infections exhibited a higher percentage of ICU admission rates in the current study.
Our study showed that Streptococcus pneumoniae was the leading cause of bacterial co-infection with H1N1, followed by
Staphylococcus aureus and Streptococcus pyogenes, consistent with the results from previous studies. 25, 26 Additionally, children with H1N1 infection and bacterial co-infection have been reported to exhibit a higher risk of severe outcomes. [26] [27] [28] In our study, patients coinfected with bacteria and H1N1 exhibited increased percentages of inpatient and ICU admissions, higher costs, and longer hospital stays. Furthermore, a significantly higher hospital mortality rate was observed in children with H1N1 and bacterial co-infections because bacterial co-infections represent an important mortality risk factor, suggesting that early empiric antibiotic treatment in severe patients may improve outcomes.
The potential limitations of our study should be mentioned.
First, the levels of selected biomarkers (PCT, CRP, and WBC) were evaluated only once. Second, our diagnostic model was derived and validated at a single hospital center and should be validated in a multicenter trial before its broad application. Finally, we also acknowledge that we may have created bias, as bacterial organisms cannot be confirmed solely through blood, sputum, and BAL culture.
| CON CLUS ION
In conclusion, we detected serum PCT and CRP levels and revealed that they represent promising biomarkers and useful clinical tools for differentiating pediatric patients with bacterial co-infections from those infected with H1N1 alone. Furthermore, the combination of PCT and CRP levels could represent a useful method for screening bacterial co-infections from H1N1 influenza infections alone in children during the early disease phase. After further validation, the flexible model reported here may assist clinicians with decisionmaking processes.
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